the fastest growth in metabolic disease prevalence is occurring in low- and middle-income countries across Southeast Asia, Sub-Saharan Africa, Latin America, and the Middle East, regions where rising caloric intake, reduced physical activity, and rapid urbanization are converging to create massive unmet therapeutic needs
doi: 10.1038/s41418-017-0012-4, 39 GaoX.LiW.SyedF.YuanF.LiP.YuQ
Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer
10.1172/jci.insight.159863 35 KoobG
If youre ready to explore whether medication is the right approach for your weight loss goals, we invite you to schedule a consultation
10.23880/oajg-16000203 132 XiaoF.LiQ.LiangK.ZhaoL.HeB.JiW.et al (2012)